ShanX Medtech

ShanX Medtech BV (SXM, NL) is developing an ultra-rapid, direct-from-specimen Antibiotic Susceptibility Testing (AST) platform device for point of care use at any healthcare setting. The device uses FLORA, their proprietary fluorescent chemistry to monitor bacterial metabolism across a panel of antibiotics. Delivering lab-grade results in as fast as one hour, the device is a simple system that requires no pre-analytical steps with seconds in hands on time, seamlessly integrating into the workflows of any physician or (hospital) laboratory technician. SXM empowers healthcare providers to administer the correct antibiotic treatment from the very first time.

SXM thrives in a highly competitive market, and their innovative, ultra-rapid platform—proven to work directly from a variety of specimens—places them at the forefront of meeting the increasing demand for advanced medical technology. This positions them to play a crucial role in the fight against antimicrobial resistance.

Keywords: Healthcare, Medical Technology, Innovation, Health Outcomes, Healthcare Providers, Hospitals, Clinics, Advanced Medical Technology, Market Disruption.